Ocular Therapeutix, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
63.74 |
55.90 |
67.05 |
120.92 |
350.30 |
731.50 |
| Przychód Δ r/r |
0.00% |
-12.30% |
19.94% |
80.34% |
189.71% |
108.82% |
| Przychód (min) |
62.41 |
51.99 |
52.72 |
120.81 |
305.93 |
638.84 |
| Przychód (max) |
64.71 |
59.97 |
83.57 |
121.02 |
412.84 |
862.09 |
| EBITDA (średnia) |
-63.74 |
-55.90 |
-67.05 |
-120.92 |
-350.30 |
-731.50 |
| EBIT (średnia) |
-63.74 |
-55.90 |
-67.05 |
-120.92 |
-350.30 |
-731.50 |
| EBIT % |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
| Zysk netto (średni) |
-186.79 |
-226.34 |
-225.20 |
-198.36 |
-55.31 |
188.99 |
| Zysk netto % |
-293.06% |
-404.90% |
-335.88% |
-164.05% |
-15.79% |
25.84% |
| EPS (średnia) |
-1.18 |
-1.43 |
-1.39 |
-1.08 |
-0.35 |
1.19 |
| Liczba analityków (Przychody) |
7 |
8 |
12 |
7 |
4 |
3 |
| Liczba analityków (EPS) |
5 |
5 |
7 |
7 |
5 |
2 |
| symbol |
OCUL |
OCUL |
OCUL |
OCUL |
OCUL |
OCUL |